Use of Insulin Glargine to Treat Diabetic Ketoacidosis

Summary

The purpose of this study is to determine the effects of the addition of insulin glargine during the early phase of moderate to severe Diabetic Ketoacidosis (DKA) in children. The investigators hypothesize that the addition of insulin glargine during the early phase of management of DKA will accelerate acidosis correction, decrease the length of insulin infusion, and decrease the total intensive care unit time in children admitted to the ICU.

Timeline

Start

2004-08

Primary completion

2009-07

Completion

2012-09

Drugs

Indications